4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 99.0%, 1g

3-Chloro-2,4-difluorobenzoyl chloride, 97.0%, 25g

2-Bromo-4-chloro-6-(trifluoromethoxy)aniline, 95.0%, 10g

Tert-butyl (5-(hydroxymethyl)pyrazin-2-yl)carbamate, 95+%, 100mg

(S)-1-(2-Fluorophenyl)ethanamine hydrochloride, 95.0%, 100mg

(2R,3S)-Dimethyl 2,3-dihydroxysuccinate, 98.0%, 100g

N-(4-Ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)thiazol-2-amine, 99.0%, 50mg

(1R,2R)-2-(1,3-dioxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)cyclohexane-1-carboxylic acid, 95+%, 100mg

Triethyl 2-acetoxypropane-1,2,3-tricarboxylate, 95.0%, 100g

5-Hydroxybenzo[de]isochromene-1,3-dione, 95.0%, 25g

GC capillary column ROTI®Cap-5 HT, 15 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Amino(imino)methanesulfonic acid, 95.0%, 250mg

(R)-3-Chloro-1,2-propanediol, 95.0%, 25g